4.7 Article

Genes and pathways differentially expressed in the brains of Fxr2 knockout mice

期刊

NEUROBIOLOGY OF DISEASE
卷 32, 期 3, 页码 510-520

出版社

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.nbd.2008.09.008

关键词

Fragile X syndrome; FXR1; FXR2; Genomics; Knockout; Mental retardation; Microarray

资金

  1. NIH [R01 HD38038]
  2. Italian Ministry of Health and the Italian Ministry of Education University and Research

向作者/读者索取更多资源

Fragile X syndrome is a common inherited form of mental retardation and originates from the absence of expression of the FMR1 gene. This gene and its two homologues, FXR1 and FXR2, encode for a family of fragile X related (FXR) proteins with similar tissue distribution, together with sequence and functional homology. Based on these characteristics, it has been suggested that these proteins might partly complement one another. To unravel the function of Fxr2 protein. the expression pattern of 12,588 genes was studied in the brains of wild-type and Fxr2 knockout mice, an animal model which shows behavioral abnormalities partly similar to those observed in Fmr1-knockout mice. By genome expression profiling and stringent significance tests we identify genes and gene groups de-regulated in the brains of Fxr2 knockout mice. Differential expression of candidate genes was validated by real-time PCR, in situ hybridization, immunohistochemistry and western blot analysis. A number of differentially expressed genes associated with the Fxr2 phenotype have been previously involved in other memory or cognitive disorders. (C) 2008 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Biochemistry & Molecular Biology

Omics Data and Their Integrative Analysis to Support Stratified Medicine in Neurodegenerative Diseases

Valentina La Cognata, Giovanna Morello, Sebastiano Cavallaro

Summary: Molecular and clinical heterogeneity pose challenges in the development of early diagnosis and effective treatment approaches for neurodegenerative diseases. Omics technologies offer a comprehensive view of molecular pathways, aiding in the differentiation of patient subtypes and advancing personalized medicine in neurology.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Biochemistry & Molecular Biology

Design and Validation of a Custom NGS Panel Targeting a Set of Lysosomal Storage Diseases Candidate for NBS Applications

Valentina La Cognata, Maria Guarnaccia, Giovanna Morello, Martino Ruggieri, Agata Polizzi, Sebastiano Cavallaro

Summary: Lysosomal storage diseases (LSDs) are a heterogeneous group of monogenic metabolic disorders with challenging diagnosis due to their variable clinical manifestations and genetic heterogeneity. Recent advancements in rapid diagnostic methods have made it possible for certain LSDs to be included in national newborn screening programs. Evaluation of a targeted next-generation sequencing panel designed for LSDs shows that it is a fast, accurate, and cost-effective process that can improve diagnostic speed and reduce costs.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Medicine, General & Internal

The Utility of Genomic Testing for Hyperphenylalaninemia

Elisabetta Anna Tendi, Maria Guarnaccia, Giovanna Morello, Sebastiano Cavallaro

Summary: Hyperphenylalaninemia (HPA) is a common amino acid metabolism disorder caused by defects in enzymes involved in phenylalanine metabolism, leading to the accumulation of phenylalanine and its secondary metabolites. Early diagnosis and treatment can improve the prognosis of affected patients. High-throughput molecular technologies can aid in accurate diagnosis and treatment determination.

JOURNAL OF CLINICAL MEDICINE (2022)

Review Neurosciences

The neuroinvasiveness, neurotropism, and neurovirulence of SARS-CoV-2

Lisa Bauer, Brigitta M. Laksono, Femke M. S. de Vrij, Steven A. Kushner, Oliver Harschnitz, Debby van Riel

Summary: This article provides an overview of neurological complications associated with SARS-CoV-2 infection and discusses their pathogenesis. It outlines the distinctions between neuroinvasiveness, neurotropism, and neurovirulence, and explores the advantages and limitations of different experimental models in advancing the field.

TRENDS IN NEUROSCIENCES (2022)

Review Health Care Sciences & Services

Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative Diseases

Giulia Gentile, Giovanna Morello, Valentina La Cognata, Maria Guarnaccia, Francesca Luisa Conforti, Sebastiano Cavallaro

Summary: Alzheimer's disease (AD), Parkinson's disease (PD), and Amyotrophic Lateral Sclerosis (ALS) are representative neurodegenerative diseases (NDs) characterized by selective neuron degeneration, with a lack of effective biomarkers and therapies. MicroRNAs (miRNAs) have shown promise in diagnostics and therapy of these NDs due to their abnormal expression and ability to target multiple molecules and pathways.

JOURNAL OF PERSONALIZED MEDICINE (2022)

Review Health Care Sciences & Services

The Advent of Omics Sciences in Clinical Trials of Motor Neuron Diseases

Paola Ruffo, Sebastiano Cavallaro, Francesca Luisa Conforti

Summary: The application of omics sciences in clinical trials for motor neuron diseases is revolutionizing their diagnosis and therapy, providing new opportunities for personalized medicine.

JOURNAL OF PERSONALIZED MEDICINE (2022)

Review Biochemistry & Molecular Biology

Detection of Structural Variants by NGS: Revealing Missing Alleles in Lysosomal Storage Diseases

Valentina La Cognata, Sebastiano Cavallaro

Summary: Lysosomal storage diseases (LSDs) are rare metabolic disorders characterized by the accumulation of non-degraded substances. Next-generation sequencing (NGS) provides a powerful tool for genetic testing in LSDs patients, allowing the detection of small and large genetic variations. However, the clinical application of NGS in diagnosing LSDs still faces challenges.

BIOMEDICINES (2022)

Article Biology

A Targeted Next-Generation Sequencing Panel to Genotype Gliomas

Maria Guarnaccia, Laura Guarnaccia, Valentina La Cognata, Stefania Elena Navone, Rolando Campanella, Antonella Ampollini, Marco Locatelli, Monica Miozzo, Giovanni Marfia, Sebastiano Cavallaro

Summary: The study developed a targeted next-generation sequencing approach for analyzing genetic variations and chromosomal aberrations in gliomas, which can provide accurate and specific assessment of tumor pathogenesis, prognosis, and treatment response. This has important implications for the diagnosis and treatment of gliomas.

LIFE-BASEL (2022)

Article Neurosciences

In vitro and in vivo differences in neurovirulence between D614G, Delta And Omicron BA.1 SARS-CoV-2 variants

Lisa Bauer, Melanie Rissmann, Feline F. W. Benavides, Lonneke Leijten, Peter van Run, Lineke Begeman, Edwin J. B. Veldhuis Kroeze, Bas Lendemeijer, Hilde Smeenk, Femke M. S. de Vrij, Steven A. Kushner, Marion P. G. Koopmans, Barry Rockx, Debby van Riel

Summary: The Delta and Omicron BA.1 variants of SARS-CoV-2 exhibit reduced neuroinvasiveness and neurovirulence compared to the ancestral strain D614G, as shown in in vitro and in vivo experiments.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2022)

Article Cell Biology

Modulating mutational outcomes and improving precise gene editing at CRISPR-Cas9-induced breaks by chemical inhibition of end-joining pathways

Joost Schimmel, Nuria Munoz-Subirana, Hanneke Kool, Robin van Schendel, Sven van der Vlies, Juliette A. Kamp, Femke de Vrij, Steven A. Kushner, Graeme C. M. Smith, Simon J. Boulton, Marcel Tijsterman

Summary: Gene editing can be improved by inhibiting non-homologous end joining (NHEJ) or polymerase theta-mediated end joining (TMEJ), which alters the outcomes of CRISPR-Cas9. Inhibiting TMEJ activity using ART558 suppresses microhomology-driven deletions and promotes NHEJ-specific outcomes. Combining TMEJ and NHEJ inhibition increases the efficiency of precise gene editing through homology-driven repair (HDR).

CELL REPORTS (2023)

Article Biochemistry & Molecular Biology

The Cleavage-Specific Tau 12A12mAb Exerts an Anti-Amyloidogenic Action by Modulating the Endocytic and Bioenergetic Pathways in Alzheimer's Disease Mouse Model

Valentina Latina, Anna Atlante, Francesca Malerba, Federico La Regina, Bijorn Omar Balzamino, Alessandra Micera, Annabella Pignataro, Egidio Stigliano, Sebastiano Cavallaro, Pietro Calissano, Giuseppina Amadoro

Summary: In addition to deficits in hippocampal-dependent episodic memory, Alzheimer's Disease (AD) is characterized by sensory impairment in visual cognition due to extensive neuropathology in the retina. A monoclonal antibody called 12A12 has been found to specifically neutralize the harmful tau fragments associated with AD without affecting the normal protein. When administered to a mouse model of AD, 12A12 successfully reduces the accumulation of these tau fragments in the brain and retina, improving the associated symptoms. This study also reveals that 12A12 downregulates the expression of proteins involved in the production of amyloid beta, leading to a decrease in its accumulation in both the hippocampus and retina.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Review Cell Biology

Cracking the Code of Neuronal Cell Fate

Giovanna Morello, Valentina La Cognata, Maria Guarnaccia, Velia D'Agata, Sebastiano Cavallaro

Summary: Transcriptional regulation is crucial in biological processes and can be deciphered through reverse-engineering programs. In this review, genomics is discussed as a tool to understand the complex and coordinated transcriptional programs controlling neuronal apoptosis and survival. Decrypting the neuronal fate code may provide insights for therapeutic approaches targeting downstream targets and regulatory networks in neurodegeneration and cancer.
Article Cell Biology

CXCR2 Is Deregulated in ALS Spinal Cord and Its Activation Triggers Apoptosis in Motor Neuron-Like Cells Overexpressing hSOD1-G93A

Valentina La Cognata, Agata Grazia D'Amico, Grazia Maugeri, Giovanna Morello, Maria Guarnaccia, Benedetta Magri, Eleonora Aronica, Velia D'Agata, Sebastiano Cavallaro

Summary: Amyotrophic lateral sclerosis (ALS) is characterized by motor neuron (MN) depletion. CXCR2 has been implicated in ALS pathology and its expression is increased in cortical neurons of sporadic ALS patients. Inhibition of CXCR2 prevents MN degeneration in vitro and improves neuromuscular function in SOD1-G93A mice.
Article Cell Biology

A Diagnostic Gene-Expression Signature in Fibroblasts of Amyotrophic Lateral Sclerosis

Giovanna Morello, Valentina La Cognata, Maria Guarnaccia, Vincenzo La Bella, Francesca Luisa Conforti, Sebastiano Cavallaro

Summary: This study characterized transcriptome changes in skin fibroblasts of ALS patients and identified 277 differentially expressed transcripts that could serve as molecular biomarkers for ALS diagnosis.
Article Biochemistry & Molecular Biology

Detection of Single-Nucleotide and Copy Number Defects Underlying Hyperphenylalaninemia by Next-Generation Sequencing

Elisabetta Anna Tendi, Giovanna Morello, Maria Guarnaccia, Valentina La Cognata, Salvatore Petralia, Maria Anna Messina, Concetta Meli, Agata Fiumara, Martino Ruggieri, Sebastiano Cavallaro

Summary: Hyperphenylalaninemia (HPA) is a common genetic disorder characterized by serious clinical manifestations. Next-generation sequencing (NGS) technology can help identify the molecular basis of this disease due to its genetic and allelic heterogeneity. We developed a targeted NGS (tNGS) approach for detecting genetic variants associated with HPA, providing a comprehensive view and optimizing patient care.

BIOMEDICINES (2023)

Article Neurosciences

Cell-type brain-region specific changes in prefrontal cortex of a mouse model of alcohol dependence

Nihal A. Salem, Lawrence Manzano, Michael W. Keist, Olga Ponomareva, Amanda J. Roberts, Marisa Roberto, R. Dayne Mayfield

Summary: This study identified cell-type specific gene expression changes associated with alcohol dependence in the medial prefrontal cortex of mice. The results revealed dysregulated gene co-expression networks and differentially expressed genes in multiple cell types, highlighting the involvement of inhibitory neurons and astrocytes in alcohol dependence. Novel targets for studying molecular mechanisms contributing to alcohol dependence were also identified.

NEUROBIOLOGY OF DISEASE (2024)

Article Neurosciences

Sex-specific developmental alterations in DYRK1A expression in the brain of a Down syndrome mouse model

Laura E. Hawley, Megan Stringer, Abigail J. Deal, Andrew Folz, Charles R. Goodlett, Randall J. Roper

Summary: This study found that the overexpression of DYRK1A protein in Down syndrome mice varies with age, sex, and brain region, and reducing the copy number of Dyrk1a can decrease the expression of DYRK1A. These sex-specific patterns of DYRK1A overexpression may provide mechanistic targets for therapeutic intervention in Down syndrome.

NEUROBIOLOGY OF DISEASE (2024)